EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Cha, Yin Lian ^a,b   Li, Pin Dong ^a,b   Yuan, Lin Jing ^a,b   Zhang, Mei Yin ^a,b   Zhang, Yao Jun ^b   Rao, Hui Lan ^b   Zhang, Hui Zhong ^b   Zheng, X F Steven ^c   Wang, Hui Yun ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; INITIATION FACTOR 4E BINDING PROTEIN 1; MESSENGER RNA; EIF4EBP1 PROTEIN, HUMAN; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PROTEIN EXPRESSION; TUMOR EMBOLISM; TUMOR ENCAPSULATION; UPREGULATION; WESTERN BLOTTING; CANCER STAGING; DISEASE COURSE; GENETICS; LIVER; LIVER TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; ALPHA-FETOPROTEINS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOSPHOPROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; YOUNG ADULT;

EID: 84922527261     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117493     Document Type: Article

References (31)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917. doi: 10.1002/ijc.25516 PMID: 21351269
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90. doi: 10.3322/caac.20107 PMID: 21296855
3. Villanueva A, Chiang DY, Newell P, Peix J, Thung S, et al. (2008) Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology 135: 1972-1983, 1983 e1971-1911. doi: 10.1053/j.gastro. 2008.08.008 PMID: 18929564
4. Zender L, Villanueva A, Tovar V, Sia D, Chiang DY, et al. (2010) Cancer gene discovery in hepatocellular carcinoma. J Hepatol 52: 921-929. doi: 10.1016/j.jhep.2009.12.034 PMID: 20385424
5. Wang C, Cigliano A, Delogu S, Armbruster J, Dombrowski F, et al. (2013) Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: implications for the treatment of human liver cancer. Cell Cycle 12: 1999-2010. doi: 10.4161/cc.25099 PMID: 23759595
6. Magnuson B, Ekim B, Fingar DC (2012) Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J 441: 1-21. doi: 10.1042/BJ20110892 PMID: 22168436
7. Li X, Li Z, Zhou W, Xing X, Huang L, et al. (2013) Overexpression of 4EBP1, p70S6K, Akt1 or Akt2 differentially promotes Coxsackievirus B3-induced apoptosis in HeLa cells. Cell Death Dis 4: e803-809. doi: 10.1038/cddis.2013.331 PMID: 24030155
8. Harris TE, Lawrence JC Jr. (2003) TOR signaling. Sci STKE 2003: re15. PMID: 14668532
9. Gingras AC, Raught B, Sonenberg N (1999) eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68: 913-963. PMID: 10872469
10. Aoyagi M, Gaspar M, Shenk TE (2010) Human cytomegalovirus UL69 protein facilitates translation by associating with the mRNA cap-binding complex and excluding 4EBP1. Proc Natl Acad Sci U S A 107: 2640-2645. doi: 10.1073/pnas.0914856107 PMID: 20133758
11. Thoreen CC (2013) Many roads from mTOR to eIF4F. Biochem Soc Trans 41: 913-916. doi: 10.1042/BST20130082 PMID: 23863155
12. Heikkinen T, Korpela T, Fagerholm R, Khan S, Aittomaki K, et al. (2013) Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment. Breast Cancer Res Treat 141: 79-88. doi: 10.1007/s10549-013-2671-2 PMID: 23974830
13. Dellas A, Torhorst J, Bachmann F, Banziger R, Schultheiss E, et al. (1998) Expression of p150 in cervical neoplasia and its potential value in predicting survival. Cancer 83: 1376-1383. PMID: 9762939
14. Chen G, Burger MM (1999) p150 expression and its prognostic value in squamous-cell carcinoma of the esophagus. Int J Cancer 84: 95-100. PMID: 10096238
15. Spilka R, Laimer K, Bachmann F, Spizzo G, Vogetseder A, et al. (2012) Overexpression of eIF3a in Squamous Cell Carcinoma of the Oral Cavity and Its Putative Relation to Chemotherapy Response. J Oncol 2012: 901956. doi: 10.1155/2012/901956 PMID: 22619676
16. Haybaeck J, O'Connor T, Spilka R, Spizzo G, Ensinger C, et al. (2010) Overexpression of p150, a part of the large subunit of the eukaryotic translation initiation factor 3, in colon cancer. Anticancer Res 30: 1047-1055. PMID: 20530408
17. Spilka R, Ernst C, Bergler H, Rainer J, Flechsig S, et al. (2014) eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation. Cell Oncol (Dordr) 37: 253-267. doi: 10.1007/s13402-014-0181-9 PMID: 25070653
18. Spilka R, Ernst C, Mehta AK, Haybaeck J (2013) Eukaryotic translation initiation factors in cancer development and progression. Cancer Lett 340: 9-21. doi: 10.1016/j.canlet.2013.06.019 PMID: 23830805
19. No JH, Jeon YT, Park IA, Kim YB, Kim JW, et al. (2011) Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer. Gynecol Oncol 121: 8-12. doi: 10.1016/j.ygyno.2010.12.364 PMID: 21276607
20. Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, et al. (2006) Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Cancer 107: 1801-1811. PMID: 16983702
21. Rojo F, Najera L, Lirola J, Jimenez J, Guzman M, et al. (2007) 4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis. Clin Cancer Res 13: 81-89. PMID: 17200342
22. Karlsson E, Perez-Tenorio G, Amin R, Bostner J, Skoog L, et al. (2013) The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials. Breast Cancer Res 15: R96. PMID: 24131622
23. Armengol G, Rojo F, Castellvi J, Iglesias C, Cuatrecasas M, et al. (2007) 4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications. Cancer Res 67: 7551-7555. PMID: 17699757
24. Martineau Y, Azar R, Bousquet C, Pyronnet S (2013) Anti-oncogenic potential of the eIF4E-binding proteins. Oncogene 32: 671-677. doi: 10.1038/onc.2012.116 PMID: 22508483
25. Cai W, Ye Q, She QB (2014) Loss of 4E-BP1 function induces EMT and promotes cancer cell migration and invasion via cap-dependent translational activation of snail. Oncotarget 5: 6015-6027. PMID: 24970798
26. Karlsson E, Waltersson MA, Bostner J, Perez-Tenorio G, Olsson B, et al. (2011) High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1. Genes Chromosomes Cancer 50: 775-787. doi: 10.1002/gcc.20900 PMID: 21748818
27. Li M, Wang J, Yang L, Gao P, Tian QB, et al. (2014) eRF3b, a biomarker for hepatocellular carcinoma, influences cell cycle and phosphoralation status of 4E-BP1. PLoS One 9: e86371. doi: 10.1371/journal.pone.0086371 PMID: 24466059
28. Weng Q, Zhang J, Cao J, Xia Q, Wang D, et al. (2011) Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1alpha expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells. Invest New Drugs 29: 1177-1187. doi: 10.1007/s10637-010-9462-y PMID: 20524035
29. Garcia-Maceira P, Mateo J (2009) Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy. Oncogene 28: 313-324. doi: 10.1038/onc.2008.398 PMID: 18978810
30. Scheper GC, Mulder J, Kleijn M, Voorma HO, Thomas AA, et al. (1997) Inactivation of eIF2B and phosphorylation of PHAS-I in heat-shocked rat hepatoma cells. J Biol Chem 272: 26850-26856. PMID: 9341116
31. Grzmil M, Huber RM, Hess D, Frank S, Hynx D, et al. (2014) MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomas. J Clin Invest 124: 742-754. doi: 10.1172/JCI70198 PMID: 24401275